It is used in the treatment of ovarian cancer, head and neck cancer, cervical cancer, Testicular cancer., breast cancer, non-Hodgkin lymphoma (NHL), blood cancer, lung cancer, bone cancer and urinary bladder cancer.
Medicince introduction including background, function, caution, etc.
Indication For The Treatment Of Acute Non-lymphocytic Leukemia, Acute Lymphocytic Leukemia And Blast Phase Of Chronic Myelocytic Leukemia.
Side Effects Hepatic And Renal Dysfunction, Neurotoxicity, Rashes, Oral And Anal Ulceration
Mechanism Of Action Cytarabine Acts Through Direct DNA Damage And Incorporation Into DNA. It Exhibits Cell Phase Specificity, Primarily Killing Cells Undergoing DNA Synthesis (S-phase) And Under Certain Conditions Blocking The Progression Of Cells From The G1 Phase To The S-phase.